Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

240.81 +5.54 (+2.35%)

Streaming Delayed Price Updated: 12:49 PM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,776,714
Open	236.80
Bid (Size)	240.77 (200)
Ask (Size)	240.87 (100)
Prev. Close	235.27
Today's Range	235.73 - 241.46
52wk Range	141.50 - 251.71
Shares Outstanding	2,628,679,824
Dividend Yield	2.16%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Fear Gauge Ascendant: VIX Hits 26 as Geopolitical Storms and 'Higher-for-Longer' Reality Grip Markets

March 24, 2026

The CBOE Volatility Index (VIX), Wall Street’s premier measure of expected stock market volatility, climbed to a reading of 26.15 this week, marking its highest sustained level in nearly two years. As...

Via MarketMinute

If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026 ↗

March 23, 2026

CNBC commentator Jim Cramer sees value in the artificial intelligence (AI) realm beyond the technology sector.

Via The Motley Fool

Performance

YTD	+16.1%	+16.1%
1 Month	-2.0%	-2.0%
3 Month	+17.0%	+17.0%
6 Month	+36.4%	+36.4%
1 Year	+47.5%	+47.5%

More News

FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market

March 23, 2026

Via MarketMinute

Johnson & Johnson (JNJ) Forecast: Extended Rally Signals Patience for Buyers ↗

March 17, 2026

Via Talk Markets

1 Dividend ETF That Could Turn $500 Monthly Into a $725,000 Portfolio That Pays $21,750 Annually ↗

March 20, 2026

Via The Motley Fool

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie ↗

March 19, 2026

Via Benzinga

2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow ↗

March 19, 2026

Via The Motley Fool

AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown

March 18, 2026

Via MarketMinute

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

March 18, 2026

Via MarketMinute

2 Stocks That Could Create Lasting Generational Wealth ↗

March 17, 2026

Via The Motley Fool

The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape

March 16, 2026

Via MarketMinute

Your Tax Refund Will Probably Be Bigger This Year. Here's What to Do With It. ↗

March 16, 2026

Via The Motley Fool

Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis

March 16, 2026

Via Finterra

Johnson & Johnson’s Trial In Early-Stage Bladder Cancer Yield Positive Safety Results ↗

March 13, 2026

Via Stocktwits

Flight to Quality: JPMorgan and Eli Lilly Emerge as Defensive Anchors Amid Geopolitical Storm

March 13, 2026

Via MarketMinute

The Best Dividend Stocks to Buy and Hold Forever ↗

March 12, 2026

Via The Motley Fool

1 No-Brainer S&P 500 Vanguard ETF to Buy Right Now for Less Than $1,000 ↗

March 12, 2026

Via The Motley Fool

The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)

March 12, 2026

Via Finterra

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

March 12, 2026

From Johnson & Johnson

Via Business Wire

End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement

March 11, 2026

Via MarketMinute

Cracks in the Bull Case: S&P 500 Breaches Key Support as Institutional Distribution Takes Hold

March 11, 2026

Via MarketMinute

Safe Haven in a Storm: Healthcare Leads Markets as Geopolitical Tensions Spark Defensive Rotation

March 10, 2026

Via MarketMinute

Quiet Outperformance From an Overlooked Dividend ETF ↗

March 09, 2026

Via MarketBeat

2 No-Brainer Dividend Stocks to Buy in 2026 ↗

March 08, 2026

Via The Motley Fool

These 7 Elite Dividend Stocks Pay $114 Billion Annually, Combined, to Their Shareholders ↗

March 08, 2026

Via The Motley Fool

Frequently Asked Questions

Is Johnson & Johnson publicly traded?

Yes, Johnson & Johnson is publicly traded.

What exchange does Johnson & Johnson trade on?

Johnson & Johnson trades on the New York Stock Exchange

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange

What is the current price of Johnson & Johnson?

The current price of Johnson & Johnson is 240.81

When was Johnson & Johnson last traded?

The last trade of Johnson & Johnson was at 03/25/26 12:49 PM ET

What is the market capitalization of Johnson & Johnson?

The market capitalization of Johnson & Johnson is 633.01B

How many shares of Johnson & Johnson are outstanding?

Johnson & Johnson has 633B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.